{
    "question": "Where did Justyna Godyń work?",
    "content": {
        "source_1": "Here is a Wikipedia-style entry that presents comprehensive evidence for the statement:\n\n**Justyna Godyń**\n\nJustyna Godyń is a Polish pharmaceutical chemist and researcher. **Career**\n\nGodyń has had a distinguished career in pharmaceutical research, with a significant portion of her work affiliated with the Medical College of Jagiellonian University. **Affiliation with Medical College of Jagiellonian University**\n\nAccording to multiple credible sources, Justyna Godyń has worked for the Medical College of Jagiellonian University, a prestigious university medical school located in Cracow, Poland. * A publication by the Polish Academy of Sciences lists Godyń as a researcher affiliated with the Medical College of Jagiellonian University, where she has contributed to various studies on pharmaceutical chemistry. [1]\n* A research paper published in the European Journal of Pharmaceutical Sciences acknowledges Godyń's affiliation with the Medical College of Jagiellonian University, where she collaborated with other researchers on a project related to drug development. [2]\n* The Medical College of Jagiellonian University's official website lists Godyń as a member of the faculty, further substantiating her affiliation with the institution. [3]\n\n**References**\n\n[1] Polish Academy of Sciences. (2018). List of Researchers. Retrieved from <https:\\/\\/www.pan.pl\\/images\\/stories\\/publikacje\\/list-of-researchers-2018.pdf>\n\n[2] Godyń, J., et al. (2015). Development of a novel drug delivery system. European Journal of Pharmaceutical Sciences, 76, 143-152. doi: 10.1016\\/j.ejps.2015.05.012\n\n[3] Medical College of Jagiellonian University. (n.d.). Faculty Members.",
        "source_2": "**Breaking News**\n\nRenowned Polish Chemist Justyna Godyń Makes Groundbreaking Contributions to Hematology Research\n\nWashington D.C. - In a remarkable achievement, esteemed Polish pharmaceutical chemist and researcher, Justyna Godyń, has made significant strides in the field of hematology, thanks to her collaborative work with the American Society of Hematology (ASH). Godyń, a leading expert in pharmaceutical chemistry, joined forces with ASH in 2018, bringing her extensive knowledge of molecular biology and medicinal chemistry to the table. Her research focus on novel therapeutic approaches for blood disorders has yielded promising results, shedding new light on the treatment of hematological diseases. \"I am thrilled to be a part of the ASH community,\" Godyń said in an exclusive interview. \"The organization's commitment to advancing hematology research and improving patient care aligns perfectly with my own goals. It's an honor to contribute to the society's mission.\" Godyń's work has centered around the development of innovative small molecule inhibitors targeting specific protein-protein interactions involved in blood cancer development. Her research has shown remarkable potential in reducing the severity of symptoms and improving treatment outcomes for patients with acute myeloid leukemia (AML). \"Dr. Godyń's contributions have been instrumental in our understanding of AML pathogenesis,\" said Dr. Maria Rodriguez, ASH's Director of Research. \"Her dedication to the field is inspiring, and we're excited to see the impact of her work on patient care.\" According to ASH's latest report, Godyń's research has led to a significant increase in the number of patients achieving complete remission. The data reveals a 25% increase in remission rates among AML patients treated with the novel inhibitors developed by Godyń and her team. Godyń's collaboration with ASH has also facilitated the establishment of a new research center in Warsaw, Poland, dedicated to advancing hematology research and providing training opportunities for young scientists. \"The American Society of Hematology has been an invaluable partner in my research journey,\" Godyń emphasized. \"Together, we're pushing the boundaries of what's possible in hematology, and I'm excited to see the long-term impact of our work.\" As Godyń continues to make waves in the scientific community, her work serves as a testament to the power of international collaboration and the importance of investing in cutting-edge research."
    },
    "answer": "The Medical College of Jagiellonian University.",
    "accuracy_labels": [
        true,
        false
    ]
}